Larimar Therapeutics
LRMR
LRMR
89 hedge funds and large institutions have $304M invested in Larimar Therapeutics in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 45 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.77% less ownership
Funds ownership: 7.65% → 5.88% (-1.8%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
94% less call options, than puts
Call options by funds: $7K | Put options by funds: $126K
Holders
89
Holding in Top 10
2
Calls
$7K
Puts
$126K
Top Buyers
| 1 | +$14.5M | |
| 2 | +$7.99M | |
| 3 | +$7.57M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$6.38M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$4.19M |
Top Sellers
| 1 | -$18.3M | |
| 2 | -$16.4M | |
| 3 | -$4.68M | |
| 4 |
AC
Armistice Capital
New York
|
-$3.93M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.56M |